NEW HORIZONS IN NEPHROLOGY: GLOMERULAR DISEASE 2024 TAILORING TREATMENT AND PATIENT PERSPECTIVE

Friday, September 20, 7:30am - 4:15pm (EDT)

Time shown in-04:00 America, New York

Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephritic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and antimetabolites, which can be associated with significant side effects and morbidity. Thus, glomerular diseases present a difficult and unique challenge to both patients and nephrologists and are associated with high treatment costs and historically, have had poor renal outcomes. There have been significant recent advances in the field in both the diagnosis and treatment of glomerular diseases. Therefore, it is important for physicians to stay current with these new approaches to managing glomerular diseases.

For more information and how to register, visit - UPENN CMIE

Add to Calendar 2024/09/20 07:30:00 2024/09/20 16:15:00 America/New_York NEW HORIZONS IN NEPHROLOGY: GLOMERULAR DISEASE 2024 TAILORING TREATMENT AND PATIENT PERSPECTIVE Glomerular disease is associated with morbidity and mortality in patients of all ages and is a common cause of end stage kidney disease. These include those that commonly present with nephrotic syndrome (minimal change disease, FSGS and membranous nephropathy), the nephritic syndrome (vasculitis, lupus nephritis and IgA nephropathy), among others. Treatment often utilizes immunosuppressive regimens such as high dose corticosteroids, alkylating agents, calcineurin inhibitors, biologics and antimetabolites, which can be associated with significant side effects and morbidity. Thus, glomerular diseases present a difficult and unique challenge to both patients and nephrologists and are associated with high treatment costs and historically, have had poor renal outcomes. There have been significant recent advances in the field in both the diagnosis and treatment of glomerular diseases. Therefore, it is important for physicians to stay current with these new approaches to managing glomerular diseases.

For more information and how to register, visit - Smilow Center, PCAM and Virtual, Philadelphia , PA false MM/DD/YYYY 30 OPAQUE abnIJWFqzzTNocytOmJD190788

Smilow Center, PCAM and Virtual, Philadelphia , PA

Link: